M. Lavaut

发表

Vitamin D2 potentiates axon regeneration.

M. Khrestchatisky, F. Féron, T. Marqueste, 2008, Journal of neurotrauma.

Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome.

P. Bonnier, L. Andrac, C. Charpin, 2004, International journal of oncology.

Endometrial Response to Sexual Steroids as Assessed by Prostaglandin F2α Output in Explant Culture and Hormone Receptor Expression

C. Charpin, L. Boubli, C. Allasia, 2000, Gynecologic and Obstetric Investigation.

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma

R. Tomasini, J. Iovanna, G. Bidaut, 2015, Proceedings of the National Academy of Sciences.

A signature predictive of disease outcome in breast carcinomas, identified by quantitative immunocytochemical assays

P. Bonnier, V. Secq, L. Andrac, 2009, International journal of cancer.

CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients.

P. Bonnier, F. Duffaud, C. Charpin, 2003, American journal of clinical pathology.

Functional recovery after peripheral nerve injury and implantation of a collagen guide.

Tanguy Marqueste, D. Guinard, F. Féron, 2009, Biomaterials.

Correlation between laminin and Type IV collagen distribution in Breast Carcinomas, and Estrogen receptors expression, Lymph Node and Vascular involvement

L. Xerri, D. Figarella-Branger, P. Casanova, 1990, Medical oncology and tumor pharmacotherapy.

Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma

R. Tomasini, J. Iovanna, N. Dusetti, 2013, Proceedings of the National Academy of Sciences.

Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling

R. Tomasini, N. Dusetti, G. Bidaut, 2015, Cell Death and Disease.

Overexpression of hypoxia‐inducible factor HIF‐1α predicts early relapse in breast cancer: Retrospective study in a series of 745 patients

P. Bonnier, Claude Allasia, Pascal Bonnier, 2005, International journal of cancer.

Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.

S. Granjeaud, C. Brun, A. Sergé, 2016, The Journal of clinical investigation.

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions

M. V. Vander Heiden, R. Tomasini, J. Iovanna, 2017, Nature Communications.

Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.

C. Charpin, L. Boubli, J. Dales, 2003, International journal of molecular medicine.

Masked Selection: A Straightforward and Flexible Approach for the Selection of Binders Against Specific Epitopes and Differentially Expressed Proteins by Phage Display*

J. Borg, S. Audebert, P. Chames, 2013, Molecular & Cellular Proteomics.

Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype.

P. Bonnier, E. Charafe-Jauffret, J. Jacquemier, 2007, Human pathology.

Epidermal growth factor receptor in breast cancer: Correlation of quantitative immunocytochemical assays to prognostic factors

P. Bonnier, L. Andrac, C. Charpin, 2004, Breast Cancer Research and Treatment.

Tumor Neoangiogenesis by CD31 and CD105 Expression Evaluation in Breast Carcinoma Tissue Microarrays

P. Bonnier, L. Andrac, C. Charpin, 2004, Clinical Cancer Research.

Localization of lactoferrin and nonspecific cross‐reacting antigen in human breast carcinomas. An immunohistochemical study using the Avidin—biotin—peroxidase complex method

J. Jacquemier, C. Charpin, M. Lavaut, 1985, Cancer.

LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.

S. Granjeaud, R. Tomasini, J. Iovanna, 2018, Cancer research.

Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression.

P. Bonnier, Jean P Dales, Stephane Garcia, 2004, Human pathology.

Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10‐year follow‐up by automated and quantitative immunocytochemical assays

P. Bonnier, L. Andrac, C. Charpin, 1998, The Journal of pathology.

FK506 induces changes in muscle properties and promotes metabosensitive nerve fiber regeneration.

F. Féron, T. Marqueste, O. Alluin, 2009, Journal of neurotrauma.

Cholecalciferol (Vitamin D3) Improves Myelination and Recovery after Nerve Injury

M. Khrestchatisky, F. Féron, T. Marqueste, 2013, PloS one.

E‐cadherin quantititive immunocytochemical assays in breast carcinomas

C. Bouvier, L. Andrac, C. Charpin, 1997, The Journal of pathology.

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

D. Birnbaum, P. Bonnier, E. Charafe-Jauffret, 2007, British Journal of Cancer.

Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.

P. Bonnier, F. Duffaud, C. Charpin, 2003, International journal of oncology.

Validation of an immunohistochemical signature predictive of 8‐year outcome for patients with breast carcinoma

D. Birnbaum, J. Iovanna, P. Bonnier, 2012, International journal of cancer.

Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk.

D. Birnbaum, J. Iovanna, P. Bonnier, 2010, International journal of oncology.

Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis.

P. Bonnier, E. Charafe-Jauffret, J. Jacquemier, 2007, International journal of oncology.

Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.

P. Bonnier, Claude Allasia, Pascal Bonnier, 2005, International journal of oncology.

[Prognostic significance of VEGF receptors, VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) in breast carcinoma].

P. Bonnier, F. Duffaud, L. Andrac, 2003, Annales de pathologie.

Quantitative immunocytochemical profile to predict early outcome of disease in triple-negative breast carcinomas.

P. Bonnier, V. Secq, L. Andrac, 2009, International journal of oncology.

CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors.

L Piana, L. Andrac, C. Charpin, 1995, American journal of clinical pathology.

Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas.

C. Bouvier, L. Andrac, C. Charpin, 1997, Human pathology.

Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas

C. Bouvier, L. Andrac, C. Charpin, 1997, International journal of cancer.

Cathepsin D immunocytochemical assays in breast carcinomas: Image analysis and correlation to prognostic factors

P. Bonnier, L. Andrac, C. Charpin, 1993, The Journal of pathology.

Overexpression of hypoxia-inducible factor HIF-1α predicts early relapse in breast cancer : a retrospective study in a series of 745 patients.

P. Bonnier, M. Silvy, C. Picard, 2005 .

Vitamin D2 potentiates axon regeneration.

M. Khrestchatisky, F. Féron, T. Marqueste, 2008, Journal of neurotrauma.